Exploitation of cytotoxicity of some essential oils for translation in cancer therapy

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Russo, Rossella ^a   Corasaniti, Maria Tiziana ^b   Bagetta, Giacinto ^a   Morrone, Luigi Antonio ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BERGAMOT OIL; CYTOTOXIC AGENT; ESSENTIAL OIL; MELISSA OFFICINALIS ESSENTIAL OIL; SALVIA ESSENTIAL OIL; TEA TREE OIL; THYME OIL; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CANCER THERAPY; DRUG CYTOTOXICITY; ETHNOPHARMACOLOGY; EVIDENCE BASED PRACTICE; HERBAL MEDICINE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MEDICINAL PLANT; MELALEUCA ALTERNIFOLIA; MELISSA OFFICINALIS; NEOPLASM; NONHUMAN; PHYTOCHEMISTRY; PRIORITY JOURNAL; REVIEW; SALVIA; THYME;

EID: 84923917576     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/397821     Document Type: Review

References (89)

1. A.K. Mukherjee, S. Basu, N. Sarkar, and A. C. Ghosh, "Advances in cancer therapy with plant based natural products," Current Medicinal Chemistry, vol. 8, no. 12, pp. 1467-1486, 2001.
2. T. Efferth, P. C.H. Li, V. S. B. Konkimalla, and B. Kaina, "From traditional Chinesemedicine to rational cancer therapy," Trends in Molecular Medicine, vol. 13, no. 8, pp. 353-361, 2007.
3. E. Turrini, L. Ferruzzi, and C. Fimognari, "Natural compounds to overcome cancer chemoresistance: toxicological and clinical issues," Expert Opinion on Drug Metabolism & Toxicology, vol. 10, no. 12, pp. 1677-1690, 2014.
4. E. Guenther, The Essential Oils, Krieger Publishing Company, Malabar, Fla, USA, 1972.
5. F. Bakkali, S. Averbeck, D. Averbeck, and M. Idaomar, "Biological effects of essential oils-a review," Food and Chemical Toxicology, vol. 46, no. 2, pp. 446-475, 2008.
6. A. E. Edris, "Pharmaceutical and therapeutic potentials of essential oils and their individual volatile constituents: a review," Phytotherapy Research, vol. 21, no. 4, pp. 308-323, 2007.
7. V. W. C. Yim, A. K. Y. Ng, H. W. H. Tsang, and A. Y. Leung, "A review on the effects of aromatherapy for patients with depressive symptoms,"The Journal of Alternative and Complementary Medicine, vol. 15, no. 2, pp. 187-195, 2009.
8. M. V. Sobral, A. L. Xavier, T. C. Lima, and D. P. de Sousa, "Antitumor activity of monoterpenes found in essential oils," The Scientific World Journal, vol. 2014, Article ID 953451, 35 pages, 2014.
9. A. Angioni, A. Barra, V. Coroneo, S. Dessi, and P. Cabras, "Chemical composition, seasonal variability, and antifungal activity of Lavandula stoechas L. ssp. stoechas essential oils from stem/leaves and flowers," Journal of Agricultural and Food Chemistry, vol. 54, no. 12, pp. 4364-4370, 2006.
10. V. Masotti, F. Juteau, J. M. Bessiere, and J. Viano, "Seasonal and phenological variations of the essential oil fromthe narrow endemic species Artemisia molinieri and its biological activities," Journal of Agricultural and Food Chemistry, vol. 51, no. 24, pp. 7115-7121, 2003.
11. D. Hanahan and R. A. Weinberg, "Thehallmarks of cancer," Cell, vol. 100, no. 1, pp. 57-70, 2000.
12. J.-F. Lesgards, N. Baldovini, N. Vidal, and S. Pietri, "Anticancer activities of essential oils constituents and synergy with conventional therapies: a review," Phytotherapy Research, vol. 28, pp. 1423-1446, 2014.
13. A. Wei and T. Shibamoto, "Antioxidant/lipoxygenase inhibitory activities and chemical compositions of selected essential oils," Journal of Agricultural and Food Chemistry, vol. 58, no. 12, pp. 7218-7225, 2010.
14. A. S. Azmi, S. H. Bhat, S. Hanif, and S. M. Hadi, "Plant polyphenols mobilize endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: a putativemechanism for anticancer properties," FEBS Letters, vol. 580, no. 2, pp. 533-538, 2006.
15. T. Tuttolomondo, S. La Bella, M. Licata et al., "Biomolecular characterization of wild sicilian oregano: phytochemical screening of essential oils and extracts, and evaluation of their antioxidant activities," Chemistry and Biodiversity, vol. 10, no. 3, pp. 411-433, 2013.
16. I. Chakurski, M. Matev, A. Kǒichev, I. Angelova, and G. Stefanov, "Treatment of chronic colitis with an herbal combination of Taraxacum officinale, Hipericum perforatum, Melissa officinaliss, Calendula officinalis and Foeniculum vulgare," Vutr Boles, vol. 20, no. 6, pp. 51-54, 1981.
17. V. L'opez, S. Mart'in, M. P. G'omez-Serranillos, M. E. Carretero, A. K. Jager, and M. I. Calvo, "Neuroprotective and neurological properties of Melissa officinalis," Neurochemical Research, vol. 34, no. 11, pp. 1955-1961, 2009.
18. L. S. Kucera and E. C. Herrmann Jr., "Antiviral substances in plants of the mint family (labiatae). I. Tannin of Melissa officinalis," Proceedings of the Society for Experimental Biology and Medicine, vol. 124, no. 3, pp. 865-869, 1967.
19. Z. Dimitrova, B. Dimov, N. Manolova, S. Pancheva, D. Ilieva, and S. Shishkov, "Antiherpes effect of Melissa officinalis L. extracts," ActaMicrobiologica Bulgarica, vol. 29, pp. 65-72, 1993.
20. A. C. de Sousa, D. S. Alviano, A. F. Blank, P. Barreto Alves, C. S. Alviano, and C. R. Gattass, "Melissa officinalis L. essential oil: antitumoral and antioxidant activities," Journal of Pharmacy and Pharmacology, vol. 56, no. 5, pp. 677-681, 2004.
21. H. Sadraei, G. Asghari, and A. Naddafi, "Relaxant effect of essential oil and hydro-alcoholic extract of Pycnocycla spinosa Decne. exBoiss. on ileum contractions," Phytotherapy Research, vol. 17, no. 6, pp. 645-649, 2003.
22. J.V. Larrondo,M. Agut, and M.A. Calvo-Torras, "Antimicrobial activity of essences fromlabiates," Microbios, vol. 82,no. 332, pp. 171-172, 1995.
23. N. Mimica-Dukic, B. Bozin, M. Sokovic, and N. Simin, "Antimicrobial and antioxidant activities of Melissa officinalis L. (Lamiaceae) essential oil," Journal of Agricultural and Food Chemistry, vol. 52, no. 9, pp. 2485-2489, 2004.
24. R. M. Queiroz, C. M. Takiya, L. P. Guimaraes et al., "Apoptosisinducing effects of Melissa officinalis L. essential oil in glioblastoma multiforme cells," Cancer Investigation, vol. 32, no. 6, pp. 226-235, 2014.
25. K. A. Hammer, C. F. Carson, T. V. Riley, and J. B. Nielsen, "A review of the toxicity of Melaleuca alternifolia (tea tree) oil," Food and Chemical Toxicology, vol. 44, no. 5, pp. 616-625, 2006.
26. J. J. Brophy, D. C. Craig, R. J. Goldsack, C. J. R. Fookes, D. N. Leach, and P. G. Waterman, "Triumphalone, a diketone from the volatile oil of the leaves of Melaleuca triumphalis, and its spontaneous conversion into isotriumphalone," Phytochemistry, vol. 67, no. 18, pp. 2085-2089, 2006.
27. F. Mondello, F. de Bernardis, A. Girolamo, A. Cassone, and G. Salvatore, "In vivo activity of terpinen-4-ol, the main bioactive component of Melaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic Candida species," BMC Infectious Diseases, vol. 6, article 158, 2006.
28. C. F. Carson, K. A. Hammer, and T. V. Riley, "Melaleuca alternifolia (tea tree) oil: a review of antimicrobial and other medicinal properties," ClinicalMicrobiology Reviews, vol. 19, no. 1, pp. 50-62, 2006.
29. C. F. Carson, B. J. Mee, and T. V. Riley, "Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus determined by time-kill, lysis, leakage, and salt tolerance assays and electronmicroscopy," Antimicrobial Agents and Chemotherapy, vol. 46, no. 6, pp. 1914-1920, 2002.
30. K. A. Hammer, C. F. Carson, and T. V. Riley, "Antifungal activity of the components of Melaleuca alternifolia (tea tree) oil," Journal of AppliedMicrobiology, vol. 95, no. 4, pp. 853-860, 2003.
31. P. Schnitzler, K. Schon, and J. Reichling, "Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture," Pharmazie, vol. 56,no. 4, pp. 343-347, 2001.
32. P. H. Hart, C. Brand, C. F. Carson, T. V. Riley, R. H. Prager, and J. J. Finlay-Jones, "Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes," Inflammation Research, vol. 49, no. 11, pp. 619-626, 2000.
33. G. Bozzuto,M. Colone, L. Toccacieli, A. Stringaro, and A. Molinari, "Tea tree oilmight combatmelanoma," PlantaMedica, vol. 77, no. 1, pp. 54-56, 2011.
34. A. J. Hayes, D. N. Leach, J. L. Markham, and B. Markovic, "In vitro cytotoxicity of Australian tea tree oil using human cell lines," Journal of Essential Oil Research, vol. 9, no. 5, pp. 15-16, 1997.
35. A. Calcabrini, A. Stringaro, L. Toccacieli et al., "Terpinen-4- ol, the main component of Melaleuca alternifolia (tea tree) oil inhibits the in vitro growth of human melanoma cells," Journal of Investigative Dermatology, vol. 122, no. 2, pp. 349-360, 2004.
36. T. A. Söderberg, A. Johansson, and R. Gref, "Toxic effects of some conifer resin acids and tea tree oil on human epithelial and fibroblast cells," Toxicology, vol. 107, no. 2, pp. 99-109, 1996.
37. J. Mikus, M. Harkenthal, D. Steverding, and J. Reichling, "In vitro effect of essential oils and isolated mono- and sesquiterpenes on Leishmania major and Trypanosoma brucei," Planta Medica, vol. 66, no. 4, pp. 366-368, 2000.
38. Y. Lavie, G. Fiucci, M. Czarny, and M. Liscovitch, "Changes in membrane microdomains and caveolae constituents in multidrug-resistant cancer cells," Lipids, vol. 34, no. 1, supplement, pp. S57-S63, 1999.
39. M. T. Santini, R. Romano, G. Rainaldi et al., "The relationship between 1H-NMR mobile lipid intensity and cholesterol in two human tumormultidrug resistant cell lines (MCF-7 and LoVo)," Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids, vol. 1531, no. 1-2, pp. 111-131, 2001.
40. R. G. C. Teepe, E. J. Koebrugge, C. W. G. M. Lowik et al., "Cytotoxic effects of topical antimicrobial and antiseptic agents on human keratinocytes in vitro," The Journal of Trauma, vol. 35, no. 1, pp. 8-19, 1993.
41. S. J. Greay, D. J. Ireland, H. T. Kissick et al., "Induction of necrosis and cell cycle arrest in murine cancer cell lines by Melaleuca alternifolia (tea tree) oil and terpinen-4-ol," Cancer Chemotherapy and Pharmacology, vol. 65, no. 5, pp. 877-888, 2010.
42. S. J. Greay, D. J. Ireland, H. T. Kissick et al., "Inhibition of established subcutaneous murine tumour growth with topical Melaleuca alternifolia (tea tree) oil," Cancer Chemotherapy and Pharmacology, vol. 66, no. 6, pp. 1095-1102, 2010.
43. D. J. Ireland, S. J. Greay, C. M. Hooper et al., "Topically applied Melaleuca alternifolia (tea tree) oil causes direct anti-cancer cytotoxicity in subcutaneous tumour bearing mice," Journal of Dermatological Science, vol. 67, no. 2, pp. 120-129, 2012.
44. G. P. P. Kamatou, N. P. Makunga, W. P. N. Ramogola, and A. M. Viljoen, "South African Salvia species: a review of biological activities and phytochemistry," Journal of Ethnopharmacology, vol. 119, no. 3, pp. 664-672, 2008.
45. A. Raal, A. Orav, and E. Arak, "Composition of the essential oil of Salvia officinalis L. fromvarious European countries," Natural Product Research, vol. 21, no. 5, pp. 406-411, 2007.
46. M.B. Farhat, M. J. Jord'an, R. Chaouech-Hamada, A. Landoulsi, and J. A. Sotomayor, "Variations in essential oil, phenolic compounds, and antioxidant activity of tunisian cultivated Salvia officinalis L.," Journal of Agricultural and Food Chemistry, vol. 57, no. 21, pp. 10349-10356, 2009.
47. M. R. Loizzo, R. Tundis, F. Menichini, A. M. Saab, and G. A. Statti, "Cytotoxic activity of essential oils from Labiatae and Lauraceae families against in vitro human tumor models," Anticancer Research, vol. 27, no. 5A, pp. 3293-3299, 2007.
48. W. S. Itani, S. H. El-Banna, S. B. Hassan, R. L. Larsson, A. Bazarbachi, and H. U. Gali-Muhtasib, "Anti colon cancer components fromlebanese sage (Salvia libanotica) essential oil: mechanistic basis," Cancer Biology and Therapy, vol. 7, no. 11, pp. 1765-1773, 2008.
49. H. U. Gali-Muhtasib and N. I. Affara, "Chemopreventive effects of sage oil on skin papillomas inmice," Phytomedicine, vol. 7, no. 2, pp. 129-136, 2000.
50. M. Kaileh, W. V. Berghe, E. Boone, T. Essawi, and G. Haegeman, "Screening of indigenous Palestinian medicinal plants for potential anti-inflammatory and cytotoxic activity," Journal of Ethnopharmacology, vol. 113, no. 3, pp. 510-516, 2007.
51. S. Sertel, T. Eichhorn, P. K. Plinkert, and T. Efferth, "Chemical composition and antiproliferative activity of essential oil from the leaves of a medicinal herb, Levisticum officinale, against UMSCC1 head and neck squamous carcinoma cells," Anticancer Research, vol. 31, no. 1, pp. 185-191, 2011.
52. V. Cardile, A. Russo, C. Formisano et al., "Essential oils of Salvia bracteata and Salvia rubifolia from Lebanon: chemical composition, antimicrobial activity and inhibitory effect on humanmelanoma cells," Journal of Ethnopharmacology, vol. 126, no. 2, pp. 265-272, 2009.
53. A. Russo, C. Formisano, D. Rigano et al., "Chemical composition and anticancer activity of essential oils of Mediterranean sage (Salvia officinalis L.) grown in different environmental conditions," Food and Chemical Toxicology, vol. 55, pp. 42-47, 2013.
54. J. Liu, H.-M. Shen, and C.-N. Ong, "Salvia miltiorrhiza inhibits cell growth and induces apoptosis in human hepatoma HepG2 cells," Cancer Letters, vol. 153, no. 1-2, pp. 85-93, 2000.
55. S. Cosentino, C. I. G. Tuberoso, B. Pisano et al., "In-vitro antimicrobial activity and chemical composition of Sardinian Thymus essential oils," Letters in Applied Microbiology, vol. 29, no. 2, pp. 130-135, 1999.
56. D. Kalemba and A. Kunicka, "Antibacterial and antifungal properties of essential oils," Current Medicinal Chemistry, vol. 10, no. 10, pp. 813-829, 2003.
57. K. Miura, H. Kikuzaki, and N. Nakatani, "Antioxidant activity of chemical components from sage (Salvia officinalis L.) and thyme (Thymus vulgaris L.) measured by the oil stability index method," Journal of Agricultural andFoodChemistry, vol. 50,no. 7, pp. 1845-1851, 2002.
58. L. Ait M'Barek, H. AitMouse,A. Jaâfari et al., "Cytotoxic effect of essential oil of thyme (Thymus broussonettii) on the IGROV1 tumor cells resistant to chemotherapy," Brazilian Journal ofMedical and Biological Research, vol. 40, no. 11, pp. 1537-1544, 2007.
59. S. Sertel, T. Eichhorn,P.K. Plinkert, and T. Efferth, "Cytotoxicity of Thymus vulgaris essential oil towards human oral cavity squamous cell carcinoma," Anticancer Research, vol. 31,no. 1, pp. 81-87, 2011.
60. Y. Zu, H. Yu, L. Liang et al., "Activities of ten essential oils towards Propionibacterium acnes and PC-3, A-549 and MCF-7 cancer cells," Molecules, vol. 15, no. 5, pp. 3200-3210, 2010.
61. L. Mondello, I. Stagno d'Alcontres, R. Del Duce, and F. Crispo, "On the genuineness of citrus essential oils. Part XL. The composition of the coumarins and psoralens of calabrian bergamot essential oil (Citrus bergamia Risso)," Flavour and Fragrance Journal, vol. 8, no. 1, pp. 17-24, 1993.
62. P. Dugo, L. Mondello, L. Dugo, R. Stancanelli, and G. Dugo, "LC-MS for the identification of oxygen heterocyclic compounds in citrus essential oils," Journal of Pharmaceutical and Biomedical Analysis, vol. 24, no. 1, pp. 147-154, 2000.
63. A. Verzera, G. Lamonica, L. Mondello, A. Trozzi, and G. Dugo, "The composition of bergamot oil," Perfumer & Flavorist, vol. 21, pp. 19-34, 1996.
64. A. Verzera, A. Trozzi, F. Gazea, G. Cicciarello, and A. Cotroneo, "Effects of rootstock on the composition of bergamot (Citrus bergamia Risso et Poiteau) essential oil," Journal of Agricultural and Food Chemistry, vol. 51, no. 1, pp. 206-210, 2003.
65. L. Romano, F. Battaglia, L. Masucci et al., "In vitro activity of bergamot natural essence and furocoumarin-free and distilled extracts, and their associations with boric acid, against clinical yeast isolates," Journal of Antimicrobial Chemotherapy, vol. 55, no. 1, pp. 110-114, 2005.
66. K. Laird, D. Armitage, and C. Phillips, "Reduction of surface contamination and biofilms of Enterococcus sp. and Staphylococcus aureus using a citrus-based vapour," Journal of Hospital Infection, vol. 80, no. 1, pp. 61-66, 2012.
67. M. Cosentino, A. Luini, R. Bombelli, M. T. Corasaniti, G. Bagetta, and F. Marino, "The essential oil of bergamot stimulates reactive oxygen species production in human polymorphonuclear leukocytes," Phytotherapy Research, vol. 28,no. 8, pp. 1232-1239, 2014.
68. G. Bagetta, L. A. Morrone, L. Rombola et al., "Neuropharmacology of the essential oil of bergamot," Fitoterapia, vol. 81, no. 6, pp. 453-461, 2010.
69. T. Sakurada, H. Kuwahata, S. Katsuyama et al., "Intraplantar injection of bergamot essential oil into the mouse hindpaw: effects on capsaicin-induced nociceptive behaviors," International Review of Neurobiology, vol. 85, pp. 237-248, 2009.
70. T. Sakurada, H. Mizoguchi, H. Kuwahata et al., "Intraplantar injection of bergamot essential oil induces peripheral antinociception mediated by opioid mechanism," Pharmacology Biochemistry and Behavior, vol. 97, no. 3, pp. 436-443, 2011.
71. S. Saiyudthong and C. A. Marsden, "Acute effects of bergamot oil on anxiety-related behaviour and corticosterone level in rats," Phytotherapy Research, vol. 25, no. 6, pp. 858-862, 2011.
72. D. Amantea, V. Fratto, S. Maida et al., "Prevention of glutamate accumulation and upregulation of phospho-Akt may account for neuroprotection afforded by bergamot essential oil against brain injury induced by focal cerebral ischemia in rat," International Review of Neurobiology, vol. 85, pp. 389-405, 2009.
73. M. T. Corasaniti, J. Maiuolo, S. Maida et al., "Cell signaling pathways in the mechanisms of neuroprotection afforded by bergamot essential oil against NMDA-induced cell death in vitro," British Journal of Pharmacology, vol. 151, no. 4, pp. 518-529, 2007.
74. L. A. Morrone, L. Rombola, C. Pelle et al., "The essential oil of bergamot enhances the levels of amino acid neurotransmitters in the hippocampus of rat: implication of monoterpene hydrocarbons," Pharmacological Research, vol. 55, no. 4, pp. 255-262, 2007.
75. L. Rombol'a, M. T. Corasaniti, D. Rotiroti et al., "Effects of systemic administration of the essential oil of bergamot (BEO) on gross behaviour and EEG power spectra recorded from the rat hippocampus and cerebral cortex," Functional Neurology, vol. 24, no. 2, pp. 107-112, 2009.
76. L. Berliocchi, A. Ciociaro, R. Russo et al., "Toxic profile of bergamot essential oil on survival and proliferation of SH-SY5Y neuroblastoma cells," Food and Chemical Toxicology, vol. 49, no. 11, pp. 2780-2792, 2011.
77. R. Russo, A. Ciociaro, L. Berliocchi et al., "Implication of limonene and linalyl acetate in cytotoxicity induced by bergamot essential oil in human neuroblastoma cells," Fitoterapia, vol. 89, no. 1, pp. 48-57, 2013.
78. C. Celia, E. Trapasso, M. Locatelli et al., "Anticancer activity of liposomal bergamot essential oil (BEO) on human neuroblastoma cells," Colloids and Surfaces B: Biointerfaces, vol. 112, pp. 548-553, 2013.
79. R. Russo, M. G. Cassiano, A. Ciociaro et al., "Role of Dlimonene in autophagy induced by bergamot essential oil in SHSY5Y neuroblastoma cells," PLoS ONE, vol. 9, no. 11, Article ID e113682, 2014.
80. C. M. Kenific and J. Debnath, "Cellular andmetabolic functions for autophagy in cancer cells," Trends in Cell Biology, vol. 25, no. 1, pp. 37-45, 2015.
81. A. R. Bilia, C. Guccione, B. Isacchi, C. Righeschi, F. Firenzuoli, and M. C. Bergonzi, "Essential oils loaded in nanosystems: a developing strategy for a successful therapeutic approach," Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID651593, 14 pages, 2014.
82. Y. Li, M.-Y. Li, L. Wang, Z.-H. Jiang, W.-Y. Li, and H. Li, "Induction of apoptosis of cultured hepatocarcinoma cell by essential oil of Artemisia annul L.," Sichuan Da Xue Xue Bao Yi Xue Ban, vol. 35, no. 3, pp. 337-339, 2004.
83. J.A. Buhagiar,M. T. C. Podesta, A. P. Wilson,M. J. Micallef, and S. Ali, "The induction of apoptosis in human melanoma, breast and ovarian cancer cell lines using an essential oil extract from the conifer Tetraclinis articulata," Anticancer Research, vol. 19, no. 6, pp. 5435-5443, 1999.
84. P. R. Sharma, D. M. Mondhe, S. Muthiah et al., "Anticancer activity of an essential oil from Cymbopogon flexuosus," Chemico-Biological Interactions, vol. 179, no. 2-3, pp. 160-168, 2009.
85. F. Maggi, R. F. Randriana, P. Rasoanaivo et al., "Chemical composition and in vitro biological activities of the essential oil of Vepris macrophylla (Baker) I. Verd. endemic to Madagascar," Chemistry and Biodiversity, vol. 10, no. 3, pp. 356-366, 2013.
86. R. P. C. Ferraz, G. M. B. Cardoso, T. B. da Silva et al., "Antitumour properties of the leaf essential oil of Xylopia frutescens Aubl. (Annonaceae)," Food Chemistry, vol. 141, no. 1, pp. 196-200, 2013.
87. L. A. Mbarek, H. A. Mouse, N. Elabbadi et al., "Anti-tumor properties of blackseed (Nigella sativa L.) extracts," Brazilian Journal of Medical and Biological Research, vol. 40, no. 6, pp. 839-847, 2007.
88. M. J. Salomi, S. C. Nair, and K. R. Panikkar, "Inhibitory effects of Nigella sativa and saffron (Crocus sativus) on chemical carcinogenesis in mice," Nutrition and Cancer, vol. 16, no. 1, pp. 67-72, 1991.
89. G. Nistico and D. Roth-Behrendt, "The European legislation (directive 2004/24/EC) brings clarification and recognition to herbal medicinal products," in Herbal Medicines: Development and Validation of Plant-Derived Medicines for Human Health, G. Bagetta, M. Cosentino, M. T. Corasaniti, and S. Sakurada, Eds., pp. 1-5, CRC Press, Taylor & Francis Group, Boca Raton, Fla, USA, 2012.